Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.4266
-0.0051 (-1.18%)
At close: Jun 11, 2026, 4:00 PM EDT
0.4181
-0.0085 (-1.99%)
After-hours: Jun 11, 2026, 7:33 PM EDT
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or -29.41% compared to the previous year.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$294,292
Profits / Employee
-$881,875
Market Cap
17.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -10 | -29.41% | 20 | 4 |
| Dec 31, 2024 | 34 | -15 | -30.61% | 33 | 1 |
| Dec 31, 2023 | 49 | -2 | -3.92% | 49 | 0 |
| Dec 31, 2022 | 51 | -9 | -15.00% | 51 | 0 |
| Dec 31, 2021 | 60 | 32 | 114.29% | 60 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Werewolf Therapeutics | 39 |
| Passage Bio | 24 |
| Lipocine | 14 |
| NewcelX | 12 |
| Cellectar Biosciences | 11 |
| Exicure | 8 |
| AEON Biopharma | 8 |
| Lexaria Bioscience | 7 |
CRIS News
- 6 days ago - Curis Proxy statement: Proxy filing - Filings
- 6 days ago - Curis Slides: Corporate presentation - Filings
- 20 days ago - Curis Proxy statement: Proxy filing - Filings
- 23 days ago - Curis Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Curis reports Q1 EPS ($1.25), consensus (29c) - TheFly
- 4 weeks ago - Curis sees cash and proceeds enough for operations into second half of FY27 - TheFly
- 4 weeks ago - Curis Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Curis Earnings release: Q1 2026 - Filings